Shaanxi Provincial Center for Disease Control and Prevention
Shaanxi Provincial Center for Disease Control and Prevention
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines | Digestive System Diseases, Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, myelitis, nervous system disorder, neuromuscular disease, parotid disorder, parotitis, poliomyelitis, rubella, salivary gland disorder, spinal cord disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-01-14 | NCT07338851 | |
| Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) | Respiratory Syncytial Virus (RSV) | Recruiting | Phase 3 | 2025-12-09 | NCT07272434 | |
| Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial | Prevent Diphtheria; Prevent Tetanus; Prevent Whooping Cough | Recruiting | Phase 3 | 2025-08-08 | NCT07112144 |